SARS-CoV-2 Post-Infection and Sepsis by Saccharomyces cerevisiae: A Fatal Case Report-Focus on Fungal Susceptibility and Potential Virulence Attributes
- PMID: 36828515
- PMCID: PMC9963862
- DOI: 10.3390/tropicalmed8020099
SARS-CoV-2 Post-Infection and Sepsis by Saccharomyces cerevisiae: A Fatal Case Report-Focus on Fungal Susceptibility and Potential Virulence Attributes
Abstract
The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for approximately 6.8 million deaths worldwide, threatening more than 753 million individuals. People with severe coronavirus disease-2019 (COVID-19) infection often exhibit an immunosuppression condition, resulting in greater chances of developing co-infections with bacteria and fungi, including opportunistic yeasts belonging to the Saccharomyces and Candida genera. In the present work, we have reported the case of a 75-year-old woman admitted at a Brazilian university hospital with an arterial ulcer in the left foot, which was being prepared for surgical amputation. The patient presented other underlying diseases and presented positive tests for COVID-19 prior to hospitalization. She received antimicrobial treatment, but her general condition worsened quickly, leading to death by septic shock after 4 days of hospitalization. Blood samples collected on the day she died were positive for yeast-like organisms, which were later identified as Saccharomyces cerevisiae by both biochemical and molecular methods. The fungal strain exhibited low minimal inhibitory concentration values for the antifungal agents tested (amphotericin B, 5-flucytosine, caspofungin, fluconazole and voriconazole), and it was able to produce important virulence factors, such as extracellular bioactive molecules (e.g., aspartic peptidase, phospholipase, esterase, phytase, catalase, hemolysin and siderophore) and biofilm. Despite the activity against planktonic cells, the antifungals were not able to impact the mature biofilm parameters (biomass and viability). Additionally, the S. cerevisiae strain caused the death of Tenebrio molitor larvae, depending on the fungal inoculum, and larvae immunosuppression with corticosteroids increased the larvae mortality rate. In conclusion, the present study highlighted the emergence of S. cerevisiae as an opportunistic fungal pathogen in immunosuppressed patients presenting several severe comorbidities, including COVID-19 infection.
Keywords: COVID-19; Tenebrio molitor; biofilm formation; fungal infection; hydrolytic enzymes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.Int J Med Microbiol. 2015 Dec;305(8):848-59. doi: 10.1016/j.ijmm.2015.08.003. Epub 2015 Aug 14. Int J Med Microbiol. 2015. PMID: 26319940
-
The Threat Called Candida haemulonii Species Complex in Rio de Janeiro State, Brazil: Focus on Antifungal Resistance and Virulence Attributes.J Fungi (Basel). 2022 May 27;8(6):574. doi: 10.3390/jof8060574. J Fungi (Basel). 2022. PMID: 35736057 Free PMC article.
-
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata.Mediators Inflamm. 2017;2017:8952878. doi: 10.1155/2017/8952878. Epub 2017 Jul 26. Mediators Inflamm. 2017. PMID: 28814823 Free PMC article.
-
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Drugs. 2009. PMID: 19275278 Review.
Cited by
-
Tropical Infectious Diseases of Global Significance: Insights and Perspectives.Trop Med Infect Dis. 2023 Sep 29;8(10):462. doi: 10.3390/tropicalmed8100462. Trop Med Infect Dis. 2023. PMID: 37888590 Free PMC article.
-
Antifungal potential of the new copper(II)-theophylline/1,10-phenanthroline complex against drug-resistant Candida species.Biometals. 2024 Apr;37(2):321-336. doi: 10.1007/s10534-023-00549-y. Epub 2023 Nov 2. Biometals. 2024. PMID: 37917351
-
Dechlorination of wastewater from shell-based glucosamine processing by mangrove wetland-derived fungi.Front Microbiol. 2023 Oct 13;14:1271286. doi: 10.3389/fmicb.2023.1271286. eCollection 2023. Front Microbiol. 2023. PMID: 37901808 Free PMC article.
-
Isolate distribution and antifungal susceptibility of Saccharomyces cerevisiae in the national regional medical center of Southwest China for women and children during 2018-2023.BMC Microbiol. 2024 Sep 14;24(1):345. doi: 10.1186/s12866-024-03506-y. BMC Microbiol. 2024. PMID: 39271978 Free PMC article.
References
-
- Musuuza J.S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS ONE. 2021;16:e0251170. doi: 10.1371/journal.pone.0251170. - DOI - PMC - PubMed
-
- Atıcı S., Soysal A., Karadeniz Cerit K., Yılmaz Ş., Aksu B., Kıyan G., Bakır M. Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: In a child in intensive care unit and review of the literature. Med. Mycol. Case Rep. 2017;15:33–35. doi: 10.1016/j.mmcr.2017.02.002. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous